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1. Abbreviations 
PPI – protein-protein interaction 
Y2H – Yeast Two-Hybrid 
Co-IP – Co-Immunoprecipitation 
MS – mass spectrometry 
NMR – nuclear magnetic resonance 
EMDB – Electron Microscopy Data Bank 
HSV-1, HHV-1 –herpes simplex virus type 1, human herpesvirus 1 
GFP – Enhanced Green Fluorescent Protein 
DIP – Database of Interacting Proteins 
HSV-2, HHV-2 – herpes simplex virus type 2, human herpesvirus 2 
VZV, HHV-3 –varicella-zoster virus, human herpesvirus 3 
EBV, HHV-4 – Epstein-Barr virus, human herpesvirus 4 
HCMV, HHV-5 – human cytomegalovirus, human herpesvirus 5 
HHV-6 – human herpesvirus 6 
HHV-7 – human herpesvirus 7 
KSHV, HHV-8 –Kaposi’s sarcoma-associated herpesvirus, human herpesvirus 8 
NCBI – National Center for Biotechnology Information 
EMBL – European Bioinformatics Institute 
DDBJ –DNA Data Bank of Japan 
PDB – Protein Data Bank 
HMM – Hidden Markov model 
PSI – Proteomics Standards Initiative 
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MI – molecular interactions 
CVSC – capsid vertex-specific component 
PFU – plaque forming unit 
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2. Summary 
Human herpesviruses are widespread human pathogens with a remarkable impact on worldwide 
public health. Despite intense decades of research, the molecular details in many aspects of their 
function remain to be fully characterized. To unravel the details of how these viruses operate, a 
thorough understanding of the relationships between the involved components is key. Here, we 
present HVint, a novel protein-protein intra-viral interaction resource for herpes simplex virus 
type 1 (HSV-1) integrating data from five external sources. To assess each interaction, we used a 
scoring scheme that takes into consideration aspects such as the type of detection method and the 
number of lines of evidence. The coverage of the initial interactome was further increased using 
evolutionary information, by importing interactions reported for other human herpesviruses. 
These latter interactions constitute, therefore, computational predictions for potential novel 
interactions in HSV-1. An independent experimental analysis was performed to confirm a subset 
of our predicted interactions. This subset covers proteins that contribute to nuclear egress and 
primary envelopment events, including VP26, pUL31, pUL40 and the recently characterized 
pUL32 and pUL21. Our findings support a coordinated crosstalk between VP26 and proteins 
such as pUL31, pUS9 and the CSVC complex, contributing to the development of a model 
describing the nuclear egress and primary envelopment pathways of newly synthesized HSV-1 
capsids. The results are also consistent with recent findings on the involvement of pUL32 in 
capsid maturation and early tegumentation events. Further, they open the door to new hypotheses 
on virus-specific regulators of pUS9-dependent transport. To make this repository of interactions 
readily accessible for the scientific community, we also developed a user-friendly and interactive 
web interface. Our approach demonstrates the power of computational predictions to assist in the 
design of targeted experiments for the discovery of novel protein-protein interactions. 	
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3. Introduction 
One important milestone towards understanding the complexity of viral infections is to unravel 
the interplay between viral proteins (the intra-viral interactome). This is particularly important 
for complex and large DNA viruses, such as human herpesviruses, which have the ability to 
express a large number of viral gene-products. For example, the genome of HSV-1 encodes for 
more than 75 viral proteins, and the levels of these proteins are temporally and spatially 
regulated during the progression of the viral infection (1). Human herpesviruses cause life-long 
infections and many human and animal diseases. The severity of symptoms ranges from cold 
sores, genital ulcers, and blisters to blindness and life-threatening conditions, including fatal 
encephalitis, meningitis and cancer (2, 3). Infections from herpesviruses are also a major threat 
to immunosuppressed patients (e.g. infected by human immunodeficiency virus) and have been 
associated with Alzheimer's disease (3, 4).  
Protein interactome studies can reveal critical biological information and shed light on 
mechanisms underlying infectious diseases (5), supporting proteome-wide annotation (6, 7) and 
the development of therapeutic strategies (8, 9). The current methods used for building protein-
protein interaction (PPI) networks mainly rely on known interactions and sequence analysis (11–
13). Recently the field has moved forward through the development of structural and functional 
proteomics techniques that include fluorescence microscopy and Mass Spectrometry (MS)-based 
approaches (6, 14–16). These techniques have helped to increase the coverage of the interactome 
in the context of infection. Several public repositories of PPI data exist, such as IntAct 
(www.ebi.ac.uk/intact/) (15). Multiple evidence lines, depending on the nature of the interaction 
itself and, importantly, the detection method used, can support each individual PPI. For example, 
evidence for PPIs can be derived from biochemical assays, such as Yeast Two-Hybrid (Y2H), 
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Co-Immunoprecipitation (Co-IP), in vitro binding assays, and protein cross-linking, which can 
be then analyzed by MS. PPIs can also be derived from Nuclear Magnetic Resonance (NMR), X-
ray crystallography and Electron Microscopy techniques. Most resources include evidences 
manually extracted from the literature. Furthermore, databases that are not explicitly dedicated to 
storing PPI data provide additional valuable resources, such as the Protein Data Bank (PDB 
www.rcsb.org/) (16) and the Electron Microscopy Data Bank (EMDB www.emdatabank.org/) 
(17), which contain structural information. Other databases gather PPIs based on information 
from multiple resources (e.g. VirHostNet www.virhostnet.prabi.fr/, STRING-DB http://string-
db.org/) (20, 21). However, constructing a PPI network from disparate sources while ensuring 
trustworthiness and high coverage is challenging. Experiments vary in terms of both reliability 
and ability to discriminate between different categories of interactions, notably direct (physical) 
versus indirect interactions (e.g. proteins belonging to the same protein complex but without 
direct physical contact) as well as transient versus stable interactions (22). Moreover, for many 
non-model organisms, the number of known PPIs remains limited, and thus there is a need to 
develop hypotheses about additional PPIs that are not yet supported by direct experimental 
evidence.  
Computational prediction of PPIs (19–23) provide the opportunity to maximize the coverage of 
interaction networks. These predictions often rely on sequence homology or machine learning 
methods (24–26). Several studies have now illustrated that transferring interaction data between 
close homologous species (i.e. interologues mapping (31)) is a suitable approach to expand PPI 
data for a given species. Computational methods for building and analyzing PPI networks have 
the potential to identify novel candidates for future experimental validation, thereby saving 
valuable time and resources (30, 32, 33).  
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In this study, we created HVint, a new database for intra-viral PPIs for an important human 
pathogen, of herpes simplex virus type 1 (HSV-1, also known as HHV-1), and derived the 
associated PPI network. To accomplish this, PPIs reported for any stage of the life cycle were 
compiled, i.e. interaction data both for proteins that are incorporated within extracellular virion 
particles and proteins that are only expressed in infected cells has been integrated. Information 
on the location of these proteins within the different structural layers of the virion particle (34, 
35), namely the capsid, the tegument and the viral envelope, was included in the annotation of 
the interactions in HVint. To further expand the HVint database, we integrated the subsets of 
data from existing databases for any stage of the virus “life cycle”, implemented a method for 
scoring multiple lines of experimental evidence, and incorporated homologous interactions from 
the other human herpesviruses of the a-, b- and g-herpesvirus sub-families. As a result, our 
network has significantly higher coverage than previous HSV-1 networks derived from existing 
databases (17, 18, 20, 36, 37), and it predicts novel interactions. We validated several of these 
predictions by affinity purification-MS using primary human fibroblasts infected with an HSV-1 
virus strain expressing the small capsid protein VP26 tagged with green fluorescent protein 
(EGFP). Lastly, we developed a user-friendly interactive web interface, which will allow the 
scientific community to readily access and analyze the interaction data. Taken together, this 
work demonstrates the value of data integration and homology transfer in predicting previously 
uncovered interactions in a complex virus such as HSV-1 and in guiding future experimental 
work. 
4. Experimental Procedures 
4.1. HVint Data Integration  
The PPI data compiled to generate our novel intra-viral protein interactome includes interactions 
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identified by a range of experimental methods drawn from multiple sources (Figures 1 and 2). 
First, data from four publicly available protein interaction databases, IntAct (15) (June 2015), 
VirHostNet 2.0 (18) (June 2015), Database of Interacting Proteins (DIP) (36) (October 2015) and 
BioGRID (37) (October 2015) were collected (38–47). Custom Perl scripts were used to parse 
the data and to select “native” interactions directly reported for HSV-1, and “homologous” 
interactions originally reported for any of the other human herpesviruses, i.e. herpes simplex 
virus type 2 (HSV-2, HHV-2), varicella-zoster virus (VZV, HHV-3), Epstein-Barr virus (EBV, 
HHV-4), human cytomegalovirus (HCMV, HHV-5), human herpesvirus 6 (HHV-6, A and B), 
human herpesvirus 7 (HHV-7) or Kaposi’s sarcoma-associated herpesvirus (KSHV, HHV-8). 
The search was conducted using taxonomy identifiers (IDs) and all reported strains for each 
species were considered. Where possible, protein IDs, as reported in the above interaction 
databases, were mapped to UniProt (48) accession numbers using the UniProt ID mapping tool 
(e.g. DIP and BioGRID interactor IDs are from a variety of databases, including UniProt (48), 
NCBI RefSeq, and EMBL/GenBank/DDBJ). In addition we collected interactions derived from 
structural evidence provided by the Protein Data Bank (PDB) (16) (June 2015). The taxonomy 
browser in PDB was used to retrieve entries associated with human herpesvirus species. The 
resultant list was manually curated to discard entries containing a single protein, and considered 
both homo- and hetero-interactions between the components. Interactions obtained from this 
latter dataset were also classified as native (from HSV-1) or homologous (from other human 
herpesvirus species) interactions according to their source species. 
4.2. Homology Transfer of Interactions 
Interactions gathered from other human herpesvirus species were included in HVint only if for a 
given interaction both interacting partners in the original species could be mapped to HSV-1 
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strain 17+ using the homology detection method described below. This same rationale was also 
applied to transfer interactions reported for any other strains of HSV-1 different from strain 17+. 
Homology relationships were defined based on the results of HHblits (49) (version 2.0.16). For 
each of the UniProt protein IDs involved in homologous species, its FASTA sequence was 
retrieved and used to generate a multiple sequence alignment against the entire UniProt Hidden 
Markov model (HMM) database (uniprot20_2012_10) with the number of iterations set to 3. An 
in-house Perl script was used to extract, where possible, the highest confidence match between 
the query and a protein in HSV-1 (any strain). The resulting HSV-1 UniProt IDs were mapped to 
HSV-1 strain 17+ (UniProt reference proteome for HSV1) via UniRef90 clusters (50) with in-
house scripts.  
The distribution of the experimental detection methods defining the interactions in our database 
is summarised in Supplementary figure 1. Y2H methods represent the largest fraction followed 
by co-immunoprecipitation techniques, with more than 90% of the interactions detected so far 
solely by Y2H experiments. However, about 50% of the interactions (213 out of 419) are 
supported by two or more lines of evidence. 
Based on prior knowledge, interactions in the network were also classified as interactions in the 
extracellular virions, i.e. taking place in extracellular viral particles, versus other interactions 
occurring during the viral lifecycle based on the classification of each of the interacting partners 
(34) (Supplementary figure 2). All network figures were rendered using Gephi (51). 
4.3. Scoring of Interaction Data 
To measure the confidence of each of the interactions in HVint, we adapted a heuristic scoring 
method, namely MIscore (52, 53). MIscore was chosen because its effectiveness as a scoring 
function capable of combining diverse factors that affect the reliability of molecular interaction 
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data is well established (53–55). First, scores are assigned to each individual piece of evidence 
for a given interaction. Aspects such as the interaction detection method(s), the type of 
interaction (e.g. co-localisation or physical association) and the number of separate studies 
reporting the interaction, are taken into account. To this end, each evidence line is rigorously 
annotated with the PSI-MI ontology (56), a controlled vocabulary developed by the Proteomics 
Standards Initiative (PSI) (57) for the standardization of molecular interaction (MI) annotation 
data (example tags are, MI:009 for “protein complementation assay” and MI:0428 for “imaging 
technique”). Next, scores from different lines of evidence are brought together to compute a 
single value per interaction. A more detailed description of MIscore can be found in (53). In our 
study, we modified the original MIscore function. The evidence inferred from homology was 
scaled according to the sequence identity between HSV-1 and the corresponding homologues, as 
follows: given a pair of interacting sequences A and B and their HSV-1 homologues A’ and B’, 
the original (unmodified) MIscore was multiplied by a scaling factor s defined as: 
s = {1 if p ≥ 40; p/40 otherwise} 
 
where p is min{sequence identity between A and A’, sequence identity between B and B’}. In 
other words, the score was scaled according to the lowest percentage identity between either of 
the interacting partners with their respective homologues. Here 40% was chosen as a 
conservative cut-off, taking into account prior studies of homology and the conservation PPIs 
between related species (53). The resulting modified MIscore scores range between 0 and 1 
(Supplementary figure 3). 
4.4. Network Analysis 
We next assessed how filtering out interactions based on MIscore cut-offs affected the network 
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topology by measuring how several network properties varied as interactions with a score below 
a certain cut-off were removed from the network. Self-interactions were not considered during 
this analysis, as they do not affect most of the network properties under study. We also analysed 
how the network changes when separating direct vs indirect interactions according to the PSI-MI 
classification. 	
4.5. Experimental Validation by Affinity Purification-Mass Spectrometry 
We used the HSV1(17+)blueLox-GFPVP26 strain, here denoted HSV1-GFPVP26, in which the 
small capsid protein VP26 has been tagged at the N-terminus with EGFP (58). As a control, we 
used the HSV1(17+)blueLox-pMCMVGFP strain, here denoted HSV1-GFP, which expresses 
EGFP alone, under the control of the murine cytomegalovirus promoter, inserted between the 
UL55 and UL56 ORFs (59). The viruses were propagated, isolated, and titered in Vero cells 
(ATCC CCL81) grown in DMEM containing 10% FBS and 1% penicillin/streptomycin, as 
previously described (60, 61). Primary human foreskin fibroblast cells (HFFs) were infected with 
HSV-1 strains at 1 plaque forming unit per cell (pfu/cell) for fluorescence microscopy or 5 
pfu/cell for immunoaffinity purification-MS studies. The immunoaffinity purifications of 
GFPVP26 or EGFP during productive HSV-1 infection were accomplished using magnetic beads 
conjugated with in-house generated rabbit anti-GFP antibodies, as previously described (60, 62). 
However, for the present work, the HSV-1 strain background was 17+, and not KOS as in our 
previous work. Furthermore, to capture additional interactions, we selected a cell 
lysis/immunoisolation buffer of intermediate stringency, namely 20 mM HEPES-KOH, pH 7.4, 
containing 0.11 M potassium acetate, 2 mM MgCl2, 0.1% Tween 20, 1 µM ZnCl2, 1 µM CaCl2, 
0.75 % Triton X-100, 200 mM NaCl, 0.2% deoxycholate, and 1/100 v/v protease inhibitor 
cocktail (Sigma). The immunoaffinity purifications of GFPVP26 and GFP were each performed 
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in three biological replicates. 
After immunoisolation of GFPVP26 and its interacting partners, the proteins were separated (~ 3 
cm) by SDS-PAGE using a 4 - 12% Bis-Tris NuPAGE gel (~3 cm), then stained with Coomassie 
blue and cut into gel slices. Gel slices were pooled to maintain approximate equal protein 
amounts (based on Coomassie blue staining) and digested in-gel with trypsin, as described (60). 
Extracted peptides from neighboring gel fractions were pooled (N = -6 fractions), desalted using 
SDB-RPS StageTips (63), concentrated to near dryness, then resuspended in 10 µl of 0.1% 
formic acid and analyzed by nanoliquid chromatography-tandem MS (nLC-MS/MS). 
Briefly, peptides (4 µl) were separated by reverse phase chromatography-nLC (Acclaim PepMap 
RSLC, 1.8 µm x 75 µm x 50 cm) at a flow rate of 250 nL/min over a 90 min ACN gradient from 
4 – 40% mobile phase B (A, 0.1% FA; B, 97% ACN in 0.1% FA) and ionized by ESI directly 
into the mass spectrometer (LTQ Orbitrap Velos equipped with an EASY-Spray ion source). The 
mass spectrometer was operated in a data-dependent acquisition mode. Each acquisition cycle 
comprised a single full-scan mass spectrum (m/z = 350-1700) in the orbitrap (r = 30,000 at m/z = 
400) followed by CID MS/MS of the top 15 most abundant ions, with dynamic exclusion 
enabled.  
MS/MS fragmentation spectra were extracted and peptide spectrum matches were obtained using 
Proteome Discoverer (ver. 1.4)/SEQUEST (ver 1.3) by searching independently against the 
forward and reverse subset of the human UniProt-SwissProt database (2013-08) appended with 
herpesvirus sequences and common contaminants (22, 910 sequences). SEQUEST search 
parameters were defined as the following: full trypsin specificity, maximum of 2 missed trypsin 
cleavages, ion precursor mass tolerance of 10 ppm, fragment ion mass tolerance of 0.5 Da, fixed 
modification of cysteine carbamidomethylation, variable modifications of methionine oxidation, 
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and serine, threonine, and tyrosine phosphorylation. The Proteome Discoverer workflow also 
included the precursor ions area detector node for MS1-based label-free quantification. Database 
search results were analyzed in Scaffold (ver. 4.6, Proteome Software, Inc) using the LFDR 
algorithm and a refinement search using the X!Tandem algorithm (Beavis Informatics), which 
specified the following additional modifications using the same search parameters as above: 
deamidation of glutamine and asparagine, acetylation of protein N-termini. The global peptide 
and protein FDR were controlled to ≤ 1%, estimated by reverse database search matches. The 
MS proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE 
(64) partner repository with the dataset PXD003599 and 10.6019/PXD003599 identifier. 
Unweighted protein spectrum counts and corresponding precursor area quantitative values were 
exported to Excel and additional filtering of the protein identifications was performed. Briefly, 
protein groups with ≥ 10 spectra in at least two out of three replicates were retained. For proteins 
identified in both GFPVP26 and the GFP controls, the spectral count fold enrichment was 
calculated for each biological replicate as the ratio of the spectral counts in each GFPVP26 
replicate and the averaged GFP samples. Viral proteins with an average enrichment ratio of ≥ 5-
fold were retained. The Top3 precursor area method, which uses the three most intense peptides 
as a measure of protein concentration (65), was used to estimate the stoichiometry of viral 
proteins co-isolated with GFPVP26. 
4.6.  Fluorescence Microscopy 
Primary human fibroblast cells were cultured as described above, except on glass cover slips, and 
infected with HSV1-GFPVP26 at a multiplicity of infection of 1 pfu/cell. At 14 hour post-
infection, cells were fixed with 2% (v/v) paraformaldehyde in PBS for 15 min at room 
temperature and prepared for imaging as previously described (60). Nuclei were stained with 
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DAPI. The subcellular localization of GFPVP26 was analyzed using a confocal microscope 
(Leica SP5) equipped with a 100x oil-immersion lens.  
4.7. Experimental Design and Statistical Rationale  
The HVint database was populated with non-redundant PPI data collated from five different 
public resources (IntAct, VirHostNet 2.0, DIP, BioGRID and PDB). In doing so, we 
distinguished between two different sets of PPI data: (a) PPIs directly reported in HSV-1 and (b) 
PPIs reported in other human herpesviruses species. HHblits was used to establish orthology-
relationships between proteins interacting in homologous human herpesviruses and HSV-1 
proteins. When HSV-1 homologous proteins were detected for both interacting partners in the 
source species, the interaction was transferred to the HSV-1 interactome and included in the 
HVint database. All PPI data in HVint was scored under the MIscore scheme, a heuristic scoring 
method designed to capture the heterogeneity of PPI data. MIscore is computed taken into 
account the annotation data for a given interaction. This annotation is defined by the HUPO PSI 
controlled vocabulary, which has been implemented by the public database members of the 
IMEx consortium (56). The final normalised scores result from the weighted sum of three 
different terms representing (a) the number of different citations reporting the interaction, (b) the 
corresponding detection method(s) used and (c) the nature of the interaction (type). An earlier 
study compared the performance of MIscore with that of the normalised score implemented in 
Mentha, a large integrative database (not containing viral interactomes) with over 570,000 PPIs 
(66). It was tested on a benchmark of 500 high confidence human PPIs (positive dataset) and 397 
non-interactions extracted from Negatome (negative dataset) (67). Around the optimal score cut-
offs for each database (0.485 for MIscore, 0.343 for the Mentha score) MIscore was shown to 
have greater accuracy, precision and recall than the Mentha score (0.76 vs 0.67, 0.70 vs 0.66 and 
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0.98 vs 0.85, respectively) (53). Our predicted interactions transferred from other human 
herpesviruses were scaled down from their originally assigned MIscore according to the 
sequence identity of each interacting protein to its corresponding HSV-1 homologue. The 
resulting scores, covering any value ranging between 0 and 1 (inclusive) with higher values 
reflecting higher confidence in the interaction. This calibrated scale was designed to allow users 
to fine-tune the selection of PPI data subsets in the database, based on their research purposes. 
A subset of computationally predicted interactions was selected as potential candidates for 
experimental validation by IP-MS. To identify this subset we studied how several parameters 
characterising the topology of the interactome changed when interactions scoring below a given 
MIscore threshold were removed from the network. The changes in network parameters were 
assessed in the entire range between 0 to 1 MIscore thresholds, in steps of 0.1. The IP-MS 
experiments isolating HSV1-GFPVP26 were performed in three biological replicates and 
compared against three biological IP-MS replicates of HSV1-GFP. In total 6 biological samples 
were subjected to GeLC-MS/MS analysis. 
5. Results 
5.1. HVint Interactome 
The computational and experimental pipeline developed in this work (see Experimental 
procedures, Figure 1) resulted in a novel HVint interactome (Figure 2). The data fed into the 
pipeline originated from five different resources (IntAct, VirHostNet, DIP, BioGRID and PDB) 
(Figures 1 and 3). PPIs reported for HSV-1 and all of the other human herpes virus species 
currently known (herpes simplex virus type 2, varicella-zoster virus, Epstein-Barr virus, human 
cytomegalovirus, human herpesviruses 6 and 7, and Kaposi’s sarcoma-associated herpesvirus) 
were collected. The latter interactions were transferred to the HSV-1 interactome only when 
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orthologues for both interacting partners in the source species (e.g. HCMV) could be found in 
the HSV-1 proteome. The resulting network comprises 73 nodes and 419 PPIs (including 36 self-
interactions), the reliability of which was assessed with a modified MIscore function (see 
Methods). The confidence values for the interactions in the network range from 0.147 to 0.972. 
Confidence values were computed using a highly integrative and experimentally-based scoring 
scheme that takes into account the type of interaction and detection method used to detect the 
interaction, as well as the number of different studies providing support for the interaction. 
Interactions were divided into two different datasets according to the source species: native 
interactions (reported in HSV-1) and homologous interactions (transferred from another human 
herpes virus species). Homologous interactions (255 in total) account for ~55% of the network, 
hence significantly increasing the size of the network beyond that of the native network (Figure 
4A). Twenty-nine interactions are present in both native and homologous PPI datasets, indicating 
conservation of PPIs between two or more herpesvirus species. These conserved herpesvirus 
PPIs involve 50 of the HSV-1 proteins, which correspond to about 70% of the HSV-1 proteome 
(Figure 4B). 98% (413) of these interactions were classified as “direct interaction” or “physical 
association” by the PSI-MI annotation, meaning the respective experimental conditions indicate 
that this interaction either involves direct physical contact or that or the molecules are in close 
proximity. 
5.2. New Interactions 
Predicted PPIs that so far have not been supported by experimental evidence are of particular 
interest, as they point to putative biological mechanisms yet to be confirmed. To investigate 
whether such predicted PPIs indeed exist for HSV-1, a subset of high confidence homologous 
interactions was subjected to experimental validation. This subset was selected from the 
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interactions in HVint having a confidence score greater than 0.4. The rationale behind this cutoff 
was that the initially observed topological properties of the interactome were barely altered for 
confidence score cut-offs in the range between 0 and 0.4 (Supplementary figure 4), but for cut-
offs between 0.4 and 0.5 drastic changes in several network parameters (including clustering 
coefficient, centralisation, density and average node degree) were observed. This calculated 
MIscore threshold is consistent with previously reported estimates of optimal cut-offs for scores 
predictions, within the range of 0.4 to 0.5 (53). We then retained PPIs derived from homology 
predictions only (i.e. only in the homologous dataset). By definition, these homology-based PPIs 
have been reported for other human herpesviruses but not yet for HSV-1. 
The resulting dataset, referred hereafter as high-confidence homologous interactions subset, 
comprises a total of 35 interactions (30 hetero-interactions and 5 self-interactions) among 28 
different proteins (Figure 5, Supplementary table 1). 28 hetero-interactions out of the 30 are 
connected in a single connected component, i.e. a group of nodes in which a path can be traced 
for any random pair of nodes (68). These interactions involve 23 proteins that have been 
annotated as being involved mainly in transcription, capsid assembly and nuclear capsid egress 
events (Supplementary table 2). The two binary interactions outside the main graph involve the 
obligate hetero-dimer gH/gL, an essential component of the herpesvirus entry machinery (69), 
and the tegument proteins pUL7 and pUL51. The minor capsid protein pUL25 is also present in 
the dataset with only one self-interaction. It is worth emphasizing that these disconnected 
components are nevertheless connected to the rest of the network when the whole interactome is 
considered (i.e. without filtering interactions). Our HVint interactome highlighted envelope 
protein pUS9 to be a hub for several potential interactions. Its predicted first neighbors, including 
VP26, the major small capsid protein (SCP), pUL17, another minor-capsid protein that interacts 
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with pUL25, and the inner tegument protein pUL36, that are known to function in capsid 
structure, maturation, and tegument association (70–74). As the function of these proteins has not 
been studied in the context of pUS9-mediated virion maturation and transport, they represent 
promising targets for future investigation. 
5.3. Validation of New Interactions 
To assess the informative value of our novel PPI network (Figure 5), we first searched the 
published literature for experimental evidence that had not been used as an input to our HVint 
(i.e. has yet to be incorporated within one of our source databases). We found recent 
experimental evidence supporting a complex formation of tegument proteins pUL7 and pUL51; 
co-immunopurification followed by MS detected this interaction, which was then confirmed and 
functionally characterized (75).  
Second, we conducted affinity purification MS-based proteomics experiments. From the 
homology-based network, we selected VP26 (pUL35) for affinity purification from a productive 
HSV-1 infection as a respective replication-competent GFP-tagged virus was available (76). 
Primary human fibroblast cells were infected with HSV1-GFP or HSV1-GFPVP26, which are 
HSV-1 (17+) strains expressing EGFP alone (control) or EGFP-tagged VP26, respectively (c.f. 
Experimental procedures and (76)). Wide field fluorescence microscopy was used to determine 
the subcellular localization of GFPVP26 following infection (Figure 6C). We focused on 14 
hours post infection (p.i.), a relatively late time point in infection when under our experimental 
conditions capsid and virus assembly are in progress (Figure 6C). Thus, this represents the stage 
of infection when VP26 is predominantly nuclear, and expected to interact with other capsid 
components. Additionally, at this stage, capsids containing VP26 are also starting to undergo 
nuclear export, and thereby expected to associate with proteins involved in capsid egress. Both of 
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these subsets of interactions, capsid-associated and nuclear egress proteins, were part of our 
predicted VP26 interactions (Figure 5). The GFP tag was used for affinity isolation of GFPVP26 
using specific, high-affinity anti-GFP antibodies under relatively stringent conditions (60). 
The immuno-isolated proteins from cells infected with HSV1-GFP or HSV1-GFPVP26 were 
digested with trypsin and analyzed by liquid chromatography-tandem MS. Viral proteins 
detected with at least 5-fold greater spectral counts in HSV1-GFPVP26 compared to the HSV1-
GFP control immuno-isolations were considered high confidence candidate interactions 
(Supplementary table 3). Although VP26 was isolated here using another HSV-1 strain and 
different lysis conditions when compared to a previous study ((60); c.f. Experimental 
procedures), 90% of the enriched interaction candidates were the same, pointing to reproducible 
findings. Importantly, our experiment confirmed two of the three predicted direct PPIs of VP26, 
specifically with pUL31 and pUL40 (Figure 6D, red edges). The third predicted association with 
pUS9 was the only predicted direct association not detected under these lysis conditions so far. 
However, we cannot exclude the possibility that pUS9 is a bona fide interaction that was not 
maintained in the applied lysis buffer. Given the relatively small size of US9 (~10 kDa and 90 
amino acids), its detectability by mass spectrometry would be more challenging than either 
pUL31 or pUL40. In fact, an in silico tryptic digestion of HSV1 US9 predicts only 1 - 3 tryptic 
peptides to be detected under our instrument configuration and methodology.  
Since immuno-affinity purification of GFPVP26 is expected to also identify indirect interacting 
partners, the proteins co-isolated with GFPVP26 were compared to the predicted, second order 
VP26 interactions (via pUL40 and pUL31, see Figure 5). Indeed, the IP-MS experimental dataset 
identified the proteins pUL32, pUL18, pUL26, pUL52, pUL21 and pUL10 (gM). Binary 
interactions between pUL40 and each of pUL32, pUL18, pUL26 and pUL52, as well as between 
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pUL31 and each of pUL26, pUL21 and gM are predicted by our high-confidence homologous 
HVint sub-network (MIscore > 0.4). Additionally, the interaction between pUL31, a nuclear 
egress protein, and pUL32, a protein suggested to contribute in efficient localization of newly 
synthesized capsids to nuclear replication compartments and DNA packaging, is present in our 
homology-transferred dataset but with scores below the 0.4 cut-off. Overall, the experimental 
immuno-affinity purification experiments provide compelling support for the homologous HVint 
network.  
5.4. Interactive Web-based HVint Interface  
All the data in HVint, including pairwise interactions, lines of evidence, and scores, are available 
for download in a standard format for molecular interactions data, namely PSI-MITAB 2.5. 
Additionally, we provide a user-friendly and intuitive interface to browse the data in a more 
straightforward and intuitive manner (http://topf-group.ismb.lon.ac.uk/hvint). The HVint 
interface displays an interactive graphical representation of the network and allows easy access 
to annotation data for individual nodes and edges. These can be selected by clicking on them or, 
in the case of nodes, specifying their UniProt ID in the provided search tool. The subnetwork 
created by the first neighbors of the selected element is then presented, together with its 
associated data (including a list of interactions, confidence scores and supporting evidence) in 
tabular form. Other functionality of the interface includes the ability to filter interactions based 
on user-defined confidence thresholds.	
6. Discussion 
HVint was originally populated with data from five major external public resources. Although 
some overlap exists in the data coming from these databases, each contributes multiple unique 
interactions. A recurrent issue in interactomics studies is the lack of network coverage, which 
21 	
severely limits the informative power of the resulting networks (77, 78). Therefore, in retrieving 
data from the five resources, we distinguished between two datasets. One dataset contained 
native interactions reported as directly detected for HSV-1, and the second one was composed of 
homologous interactions detected in any of the other human herpesvirus species, covering all 
three herpesvirus sub-families. The latter dataset was then used to predict PPIs in HSV-1 based 
on orthology relationships between the interacting partners in the homologous species and HSV-
1 proteins. Integrating these data increased the network coverage by more than two-fold. More 
importantly, it provides a set of putative novel interactions to be validated in HSV-1. To provide 
a measure of the quality and reliability of the data in the database, we implemented the MIscore 
(53) scoring function in our protocol. MIscore integrates data from multiple experiments that 
report a given interaction to calculate an overall confidence score, which is normalized to the 
interval [0,1]. It calculates weighted scores based on key variables: experimental detection 
method(s) (e.g. biophysical, imaging), type of interaction (e.g. physical association, co-
localisation), and number of different scientific publications reporting it. In our implementation 
we gave lower weighting to orthology-transferred interactions by penalizing their original score 
in a sequence-identity dependent manner. An advantage of implementing this scoring scheme 
was that it yielded a calibrated series of scores (ranging from 0 to 1), which allowed for fine-
tuned selection of sets of interactions based on their confidence levels. We used this approach to 
select a subset of high-confidence interactions for further experimental testing. 
Overall, our interactome, including 419 interactions, achieved a notably larger coverage than any 
individual source database alone. This set is split between 195 native and 255 homologuous 
interactions, with a small subset of them overlapping between the two (31 interactions), and it 
covers all 77 proteins in the HSV-1 reference proteome (as reported in UniProt (48)). The data 
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integration framework used in this study (Figure 1) is automated and relatively simple, which 
will allow future updates to be implemented easily as new interaction data becomes available. 
The prevalence of Y2H experiments in protein-protein interaction studies (79) is reflected in the 
large fraction of interactions obtained by this method in HVint (~90%, 380 interactions). This is 
due to the ability of Y2H experiments to determine physical pairwise interactions between 
potentially interacting partners, and from the feasibility of conducting both small- and large-scale 
screenings. Since the publication of the first large-scale protein interactions map for S. cerevisiae 
in 2000 (80), multiple studies have followed and several caveats have been raised regarding the 
interpretation and reliability of Y2H data, especially when obtained from high-throughput 
screenings (81). The main concern is the larger false positive and false negative rates than in 
previous traditional small-scale approaches. This has demanded a continued optimization of the 
technique (as shown in recent reports (79, 81–83)), and the development of a range of alternative 
hybrid strategies to complement Y2H datasets (79). These approaches have minimized the error 
rate in more recent data, suggesting that in the future the reliability of Y2H data could be 
assessed on a per-dataset basis in the future. HVint includes data derived from Y2H experiments 
across a broad period of time. Consequently, we could not yet, at present, systematically assess 
the quality of each dataset (as this is not reflected in the source databases). The use of MIscore as 
a scoring method is advantageous in this respect; it assigns comparatively low scores to 
interactions detected by Y2H experiments, thereby representing a conservative approach in 
assessing the confidence of these interactions. 
To test the predictive power of our computationally derived interaction dataset, we subjected a 
subset of PPIs with high-confidence scores to experimental validation. To this end, a number of 
homologous-only interactions that scored above 0.4 were selected. We focused our own 
23 	
validation analysis on VP26 (encoded by UL35), since it is a protein whose functions are still 
unclear, and since several HSV-1 strains in the F, 17+ and KOS background have been generated, 
in which VP26 has been successfully tagged with fluorescent proteins without or with minor 
impairment of HSV-1 propagation (58, 60, 84–87).  Hexamers of VP26 are located on top of the 
capsid hexons, which are hexamers of VP5, but not on the pentons, which are pentamers of VP5. 
VP26 is therefore perfectly placed on the capsid surface for interactions with other viral and 
cellular components (74, 76, 88, 89). Mutants of pseudorabies virus (PRV), a porcine a-
herpesvirus, or of HSV-1, that lack VP26, are less neuroinvasive and neurovirulent and grow to 
lower titers than their respective parental strains (85, 90–92). VP26 can interact with the dynein 
light chains of the Tctex family in Y2H and coIP experiments. However, it is not required for 
efficient dynein-mediated transport towards the nucleus during cell entry, and dynein does not 
bind to un-tegumented capsids that expose VP26 over their entire surface (74, 76, 84, 93). 
Homologous small capsid proteins of other herpesviruses have been shown to contribute to 
capsid stability (94, 95).	
Our HVint homologous subnetwork predicts that VP26 is associated with pUL31 and pUL40 
(Figure 7). This is supported by our experimental immuno-affinity isolation studies. VP26 is 
present in the mature virion particle, whereas pUL31 and pUL40 are not part of it (34, 88, 89, 
96–99). Hence these interactions may be particularly relevant in understanding the role of VP26 
in the viral life cycle. Notably, VP26 was also co-isolated with pUL34, one of the known binding 
partners of pUL31 (Supplementary table 3). Together, pUL31 and pUL34 form the so-called 
nuclear egress complex, which is anchored to the inner nuclear membrane by the C-terminal 
domain of pUL34 and faces the nuclear lumen (99, 100). Given the conservation of the 
interaction between pUL31 and pUL34 and their respective orthologues across the entire 
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Herpesviridae family (101), many studies have explored their roles in the early steps of the 
capsid assembly and the nuclear egress pathway. Besides being recruited directly to pUL34 at 
the inner nuclear envelope, pUL31 has also been reported to interact via its N-terminal domain to 
newly synthesized nuclear capsids (102). The pUL31-bound capsids are then thought to be 
translocated to the inner nuclear membrane, where they associate via UL31 with pUL34 to 
mediate capsid egress from the nucleoplasm to the cytosol (102). Overall, the localization of 
VP26 to the capsid surface except the vertices, its documented roles in capsid trafficking, and 
our computational and experimental findings of VP26 association with nuclear egress and CVSC 
complexes, suggests an as yet unknown role for VP26 in enforcing capsid stability and 
coordinating intra-nuclear capsid trafficking events (Figure 7). Further, the recent in situ analyses 
of the NEC architecture revealed a curved hexagonal lattice for PRV (103, 104). As pUL31 and 
pUL34 are highly conserved in the Herpesviridae this architecture is highly likely to be evident 
in HSV-1 as well. Therefore, an attractive hypothesis is that VP26 hexamers and pUL31/34 
hexamers interact directly with each other. Future, in situ analysis will need to show whether this 
is in fact the case. 
Another pair of viral proteins, pUL39 and pUL40, which constitute the small and the large 
subunits (RR1 and RR2, respectively) of the heterotetrameric HSV-1 ribonucleotide reductase 
complex (105–108), were also co-isolated with VP26 by IP-MS analysis. Intriguingly, the latter 
was also predicted to interact with VP26 in our homologous sub-network. In addition to this 
enzymatic function, several studies have highlighted a role for pUL39 as a virulence factor (106, 
108–110), for instance by interfering with apoptotic cascades (106, 109–111). This again 
suggests a potential role for VP26 in the early events of virus replication. Our experimental 
validation supports the interaction between VP26 via pUL40 to pUL39 and further to each of 
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pUL32, pUL18 (VP23) and one or more products of the HSV-1 UL26 gene, which encodes for 
an autocatalytic protease that is processed into the scaffold proteins VP24 and VP21 (112, 113). 
Notably, all these interactions have been predicted in our homologous subnetwork. Further, a 
recent study has provided new insights into a possible role of pUL32 as a chaperone-like protein 
capable of modulating capsid maturation and tegument acquisition by interacting with the capsid 
proteins pUL6 (the portal protein), pUL25, and pUL38 (VP19c) as well as the inner tegument 
protein pUL36) (114).  
Amongst the membrane proteins, our HVint interactome provides a particularly high number of 
novel interactions for pUS9. pUS9 is a small type II membrane protein of about 10 kDa that 
localizes to the trans-Golgi network and axonal vesicles of neuronal cells (115–117). Our HSV-1 
interactome predicts interactions between pUS9 and the capsid proteins VP26 and pUL17, as 
well as the inner-tegument protein	 pUL36. pUL17 and pUL25 form the Capsid Vertex-specific 
component (CVSC) located on the pentons edges and pUL17 and pUL25 are both required for 
stable DNA packaging into capsids prior to nuclear egress (70, 118, 119). pUL36 is an inner 
protein known to be involved in early tegumentation events together with its binding partner 
pUL37 (72, 84). Like the CVSC, the complex pUL36-pUL37 is also located around penton 
vertices. Interestingly, PPIs and coordinated events between pUL36-pUL37 and CVSC have 
been previously shown (72). Together with the heterodimer gE/gI, pUS9 mediates anterograde 
axonal transport of viral tegument, glycoproteins and virions of a-herpesviruses in neurons, but 
these proteins are not essential for replication in epithelial or fibroblasts cells (40–42). While 
studies on the gE/gI and pUS9-mediated transport of PRV structures show that PRV is 
transported along axons as fully assembled virions in transport vesicles, the data on HSV-1 
regarding the sub-viral and viral particles being targeted to axons is still controversial (116, 117, 
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120). Since the HSV-1 or PRV proteins that might contribute to these differences are not known, 
our novel predicted interactions from HVint generate new hypotheses on potentially virus-
specific regulators of US9-dependent anterograde transport. 
The nodes outside the main cluster of the 35 new interactions involve those forming two 
heterodimers conserved across the entire Herpesviridae family, namely gH/gL and pUL51-pUL7, 
and one self-interaction for pUL25. The complex gH/gL was structurally solved in HSV-2 by X-
ray crystallography in 2010 (121). Given the high confidence of the experimental data and the 
degree of sequence similarity between HSV-1 and HSV-2 gH/gL sequences, the existence of this 
complex in HSV-1 is undisputed (121–123). Although its specific role is yet to be fully defined, 
it is likely involved in regulating the activity of the membrane fusion glycoprotein gB (121). 
Finally, complex formation between pUL51 and pUL7, as predicted in our HVint database, was 
confirmed recently by affinity purification and tandem MS experiments (75). At the time of 
writing, these data were not integrated, to the source PPI databases used in this work. pUL51 and 
pUL7 are both conserved across the whole Herpesviridae family. pUL51 is an N-terminus 
membrane-anchored tegument protein (124–126) with no apparent enzymatic function, 
suggested to play a role in viral egress, viral envelopment and epithelial cell-to-cell spread (127, 
128). Its interaction with pUL7 seems to be required for efficient recruitment of the latter to 
cytoplasmic membranes leading to its incorporation into the virion. Both proteins partially co-
localize in cytoplasmic membranes together, as observed in the case of pUS9, with glycoprotein 
gE (128). This implies that the complex is non-obligate and each protein could carry out 
independent functional activities. pUL7 was also found inside the nuclear and cytoplasmic 
compartments in the absence of pUL51, and interactions between pUL7 and capsid proteins have 
been reported. As in the case of pUS9, the complex between pUL51 and pUL7 supports the idea 
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that viral membrane proteins are principal agents in tegumentation and secondary envelopment 
processes. By establishing interactions with capsid and capsid-associated proteins they guide 
progeny virion particles to different cytoplasmic compartments (e.g. trans Golgi network or 
endosomes) until they reach the plasma membrane (42, 129–134). 
7. Conclusions 
Here we introduce the HVint database, an integrative resource for HSV-1 molecular interaction 
data. The database contains interactions experimentally detected in HSV-1 species and 
computationally predicted using evolutionary information. Interactions in the database have been 
scored, thus confidently providing novel predicted interactions. Consequently, HVint can be used 
as a tool to prioritize candidate interactions for future experimental testing. The protocol used to 
create and populate the database was kept simple, hence facilitating database updates. In the 
future, our aim is to further improve our methods for assessing the reliability of molecular 
interaction data and to include more advanced features in the HVint graphical interface to 
accommodate users’ needs. We also plan to extend the current database to other human 
herpesvirus species and to virus-host interactions.  
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Figure legends: 
Figure 1: Workflow procedure to generate and process protein-protein interaction data for the 
HVint database. 
Figure 2: Circular layout of the novel PPI network. The respective node size indicates the 
number of interacting partners for each protein (degree). The edge width is scaled according to 
the confidence score associated with the interaction. Nodes are colour-coded according to the 
respective protein location in the virion particles – grey: protein has not been detected in virions 
by MS by Loret et al. 2008 (34); cyan – capsid or capsid-associated protein; orange – tegument 
protein; yellow – envelope glycoprotein; dark blue – other envelope protein (not glycoproteins). 
Figure 3: Venn diagram showing the total number of non-redundant PPIs in the source public 
databases, i.e. IntAct (6-2015), VirHostNet (VHN; 6-2015), DIP (10-2015), BioGRID (10-2015) 
and PDB (6-2015). Numbers in parentheses refer to the total number of interactions originating 
from each source database. Numbers inside the coloured areas indicate the degree of overlap 
between datasets. Empty subsets indicate zero overlap. 
Figure 4: (A) Venn diagram showing the total number of non-redundant PPIs in the novel HVint 
database classified as native and homologous interactions, respectively. The numbers in 
parenthesis refer to the total number of PPIs; the numbers inside the circles indicate the degree of 
dataset overlap. (B) Venn diagram showing the number of non-redundant proteins involved in 
PPIs in the HVint database. Proteins are involved in native and/or homologous interactions. The 
numbers in parenthesis refer to the number of non-redundant proteins in the respective dataset 
with the numbers inside the circles indicating the degree of dataset overlap. 
Figure 5: Sub-network highlighting homologous PPIs with a MIscore > 0.4 in red 
(Supplementary table 2). The node size indicates the number of interacting partners for each 
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protein (degree). Edge width is scaled according to the confidence score associated with the PPI. 
The nodes are colour-coded according to the protein location in the virion particles – grey: 
protein has not been detected in virions by MS by Loret et al. (34); cyan – capsid and capsid-
associated protein; orange – tegument protein; yellow – envelope glycoprotein; dark blue – 
envelope protein (not glycoprotein). 
Figure 6: Validation of homologous PPIs by IP-MS. (A) Schematic of the HSV-1 (strain 17+) 
genome indicating the locus (UL35 gene) that encodes for GFP-tagged VP26. (B) Experimental 
design for IP-MS validation of predicted VP26 protein interactions. Primary human fibroblasts 
were infected with HSV1 GFP or HSV1 GFPVP26, then collected and cryogenically lysed. 
GFPVP26 and control GFP were immuno-affinity purified from cell lysates using α-GFP 
antibodies conjugated to magnetic beads. Co-isolated proteins were eluted from the beads and 
resolved by SDS-PAGE, followed by nLC-MS/MS analysis. (C) Fluorescence microscopy of 
human foreskin fibroblasts infected with HSV1-GFPVP26. The cellular localization of GFP-
tagged VP26 was visualized by direct fluorescence (green) at 14 hrs post-infection (hpi). Nuclei 
were stained by DAPI (blue). Scale bar = 20 µm. (D) The HVint sub-network of homologous 
predicted PPIs (Figure 5) was annotated to indicate PPIs that were co-isolated with VP26 
(pUL35) by IP-MS. Both direct (red edges) and indirect, secondary (blue edges) PPIs are 
highlighted.  
Figure 7: Novel interactions predicted by HVint and supported by IP-MS experiments (Figure 6) 
in the context of the viral life cycle. Proteins are colour-coded according to the protein location 
in the virion particles – grey: protein has not been detected in virions by MS by Loret et al. 2008 
(34); cyan – capsid and capsid-associated protein; orange – tegument protein; yellow – envelope 
glycoprotein. Solid lines indicate predicted interactions in HSV-1 with MIscore > 0.4; dashed 
50 	
lines indicate predicted interactions with MIscore ≤ 0.4. Both direct (red edges) and indirect, 
secondary (blue edges) PPIs are highlighted. 
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Figure 1. (Location: Experimental Procedures – Scoring of Interaction Data; Results – HVint 
Interactome) 
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Figure 2. (Location: Results – HVint Interactome) 
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Figure 3. (Location: Results – HVint Interactome) 
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Figure 4. (Location: Results – HVint Interactome) 
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Figure 5. (Location: Results – New Interactions; Results – Validation of New Interactions) 
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Figure 6. (Location: Results – Validation of New Interactions) 
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Figure 7. (Location: Discussion) 
 
 
